Immediate Impact
13 from Science/Nature 77 standout
Citing Papers
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616
2023 Standout
Works of Phillip D. Toth being referenced
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
2014 Standout
Low‐dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low‐density lipoprotein cholesterol in patients with primary hypercholesterolemia
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Phillip D. Toth | 1214 | 227 | 559 | 373 | 25 | 1.8k | |
| Ana Filipa Macedo | 945 | 436 | 442 | 518 | 19 | 2.0k | |
| A.F.H. Stalenhoef | 1216 | 582 | 759 | 136 | 42 | 2.2k | |
| Barry Gumbiner | 1272 | 263 | 1110 | 294 | 51 | 2.6k | |
| Jonathan L. Isaacsohn | 1458 | 571 | 711 | 262 | 50 | 2.3k | |
| Maud N. Vissers | 1564 | 350 | 581 | 175 | 47 | 2.5k | |
| Paul L. Canner | 1437 | 853 | 1096 | 290 | 43 | 2.8k | |
| Jean Charles Fruchart | 1558 | 563 | 626 | 179 | 26 | 2.7k | |
| Fergus McTaggart | 949 | 158 | 367 | 239 | 33 | 1.6k | |
| Kathleen Wyne | 960 | 443 | 954 | 141 | 62 | 2.4k | |
| Kenneth G. Berge | 1149 | 450 | 951 | 171 | 26 | 1.9k |
All Works
Loading papers...